February 12, 2018 by Balika Sonthalia, Michael Zimmerman, Vishal Bhandari and Chain Drug Review
A.T. Kearney, Balika Sonthalia, CNO, crowdsourced network optimization, crowdsourcing, Michael Zimmerman, Vishal Bhandari
2018, Issue 02-12-2018, Issues, Opinion
A perfect storm is brewing for drug retailers’ supply chain managers, third-party logistics suppliers (3PLs) and the carriers they work with. After U.S. logistics costs declined 1.5% in 2016, the first half of 2017 was flat due to lingering overcapacity and rate pressures that had shippers asking for — and still getting — rate reductions.
December 11, 2017 by Carol Cruickshank, Bachul Koul and Chain Drug Review
A.T. Kearney, Bachul Koul, Carol Cruickshank, Millennial consumers, Millennial shoppers
Issue 12-11-2017, Leading Headlines, Opinion
Millennials have been a hot topic of conversation for more than a decade. It’s the one generational group that continues to confound both employers and retailers: How do we attract them, engage them and retain them? Yet a majority of employees and shoppers are them. Identified as those born between 1981 and 1997, Millennials became
November 6, 2017 by Per Hong and Chain Drug Review
A.T. Kearney, Health@250, Per Hong
2017, Issue 11-06-2017, Issues, Opinion
The impact of a healthy population and vibrant workforce on the ability of the economy to sustain growth should not be underestimated. While Congress has been mired in a political debate around the near-term costs and burden of the Affordable Care Act, lost from this deeply partisan discussion is a tangible, forward-thinking consideration of the
October 23, 2017 by Michael Dart, Adam Pressman and Chain Drug Review
A.T. Kearney, Adam Pressman, chain drug retailers, chain drug retailing, Consumers@250, Michael Dart
2017, Issue 10-23-2017, Issues, Opinion
The American economist Edgar Fiedler appropriately warned that “he who lives by the crystal ball soon learns to eat ground glass.” Fiedler aside, chain drug retailers may want to consider a series of future commercial opportunities emerging from what — at least at times — might appear to be the disruptive chaos of today’s market.
October 9, 2017 by Todd Huseby and Chain Drug Review
A.T. Kearney, A.T. Kearney’s Global Business Policy Council, America@250, Todd Huseby
2017, Issue 10-09-2017, Issues, Opinion
On July 4, 2026, when America marks its 250th birthday, will the nation be stable and prosperous? That is the core question behind America@250 — a multiyear initiative launched by A.T. Kearney, in partnership with The Wall Street Journal. Muhtar Kent of Coca-Cola Co., Chip Bergh of Levi Strauss, Rhonda Vetere of Estée Lauder Cos.,
July 3, 2017 by Rodey Wing, Ella Berlyand, Katy Rauen and Chain Drug Review
A.T. Kearney, accredited URAC pharmacy, Ella Berlyand, Katy Rauen, limited-distribution drugs, Rodey Wing, specialty pharmacy, specialty pharmacy industry
2017, Issue 07-03-2017, Issues, Opinion
In recent years, the specialty pharmacy industry has been defined by rapid growth with considerable entry from new participants. Factors driving growth include an increase of therapies introduced into the pharmacy benefit class rather than through the medical benefit, a growing number of patients receiving treatment for a wider range of conditions, price inflation caused
June 13, 2017 by Hana Ben-Shabat and Chain Drug Review
A.T. Kearney, Beauty and the E-Commerce Beast, Hana Ben-Shabat, online sales of beauty and personal care products, online shoppers
Opinion
Online sales of beauty and personal care products are on the rise, and further penetration is expected. Yet one tough question is keeping online sellers awake at night: Will online’s convenient delivery, wider product selection, competitive pricing and access to information complement the in-store experience, or will it instead cripple traditional retailers’ sales and margins?
April 28, 2017 by Chain Drug Review
A.T. Kearney, beauty and personal care e-commerce, Beauty and the E-Commerce Beast, Hana Ben-Shabat, online beauty shoppers, online beauty shopping
Leading Headlines, Retail News
NEW YORK — Amazon is consumers’ retailer of choice when shopping for beauty products online, followed by specialty chains Sephora and Ulta, and discount store giant Walmart, according to A.T. Kearney’s latest beauty and personal care e-commerce study. Of 800 U.S. online beauty shoppers surveyed by A.T. Kearney, 69% said Amazon is where they search
April 24, 2017 by Todd Huseby, Jim Singer and Chain Drug Review
A.T. Kearney, BAT, Border Adjustment Tax, chain drug operators, chain drug store, Jim Singer, NAFTA, Todd Huseby
2017, Issue 04-24-2017, Issues, Opinion
Staying competitive in the fast-moving chain drug store world is hard enough in the best of times. But things may be about to get even tougher. Chain drug operators with significant imports, and the corresponding consumer packaged goods partners, now face potentially significant challenges to their profitability in the form of the uncertainty and mixed-signals
March 23, 2017 by Hana Ben-Shabat and Chain Drug Review
A.T. Kearney, A.T. Kearney’s Merger End Game Methodology, Hana Ben-Shabat, U.S. beauty and personal care market
2017, Issue 03-13-2017, Issues, Opinion
The U.S. beauty and personal care market has been barely inching upward, with only 3% growth over the past five years. As the next five years don’t hold out great hope of any faster gains, industry leaders have been seeking bigger returns through inorganic growth — which has often meant acquiring both smaller, more innovative
August 16, 2016 by Chris Paddison and Chain Drug Review
A.T. Kearney, chain drug store, Chris Paddison, Digital Disruption, digital technologies, retail pharmacy
Opinion
The explosion of data, analytics, and insights is shifting the ways that health care companies can create value. In a roundtable I recently facilitated on this subject at an industry summit, three themes emerged. First, companies across the entire health care value chain need scale to make the appropriate investments. Second, they need to focus
August 7, 2016 by Jeff Hewitt and Chain Drug Review
A.T. Kearney, digital data, Digital Disruption, digital pharmacies, electronic health records, health analytics, health care, Jeff Hewitt
Leading Headlines, Opinion, Technology
The digital data universe is growing dramatically — doubling every two years by some estimates. But when it comes to the implications for health care, pragmatic questions remain: What are the possibilities of new applications that capitalize on digitized data? Why isn’t change happening faster? And what barriers are preventing adoption? I recently had the
August 6, 2016 by Chain Drug Review
A.T. Kearney, Bob O’Meara, Chain Drug Review, Digital Disruption, health care technology, Jeffrey Woldt, Matter, pharmacy chains, retail pharmacy, Steven Collens, Todd Huseby
2016, Issue 08-08-2016, Issues, News, Retail News, Technology
CHICAGO — Retail pharmacy is no stranger to technology. For many years pharmacy operators and their supply chain partners have relied on computer-driven systems to ensure efficient distribution of products, assist pharmacists in dispensing and adjudicate insurance claims. The digital revolution is now bringing about an exponential change in technology’s impact not only on pharmacy,
August 3, 2016 by Todd Huseby, Bob O'Meara and Chain Drug Review
A.T. Kearney, Bob O’Meara, community pharmacy, pharmacy retailers, retail pharmacy industry, Todd Huseby
Leading Headlines, Opinion
With massive change in the retail pharmacy industry — including mergers and acquisitions, downward pressure on reimbursement rates, consolidation of payers, and a nascent movement to transform pharmacists into providers — now is a good time to take a step back and look at the big picture. What forces will transform the industry, and which